The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 19, 2026

Filed:

Sep. 16, 2021
Applicant:

Omic Smap Inc., Seoul, KR;

Inventors:

Jung Jin Hwang, Seoul, KR;

Sang Eun Park, Seoul, KR;

Dong Eun Kim, Seoul, KR;

Ji-Ye Hong, Seoul, KR;

Choung-Soo Kim, Seoul, KR;

Woo Chan Son, Seoul, KR;

Shinae Kim, Daegu, KR;

Sugyeong Kwon, Daegu, KR;

Kyungjin Jung, Daegu, KR;

Nayeon Kim, Daegu, KR;

Jina Kim, Daegu, KR;

Kyung-Hee Kim, Daegu, KR;

Jung Wook Chin, Daegu, KR;

Sung Jin Cho, Daegu, KR;

Sehan Lee, Daegu, KR;

Eunju Cha, Daegu, KR;

Jeongmin Joo, Daegu, KR;

Ji Sun Hwang, Daegu, KR;

Jeong-Eun Park, Daegu, KR;

Ji Hoon Yu, Daegu, KR;

Eunmi Hong, Daegu, KR;

Young-Hoon Park, Daegu, KR;

Ju-Hee Lee, Daegu, KR;

Assignee:

OMIC Smap Inc., Seoul, KR;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 401/14 (2006.01); A61K 45/06 (2006.01); A61P 35/00 (2006.01); C07D 239/95 (2006.01); C07D 401/12 (2006.01);
U.S. Cl.
CPC ...
C07D 401/14 (2013.01); A61K 45/06 (2013.01); A61P 35/00 (2018.01); C07D 239/95 (2013.01); C07D 401/12 (2013.01);
Abstract

A compound, a stereoisomer thereof, a hydrate thereof, or a pharmaceutically acceptable salt thereof, provided as one aspect of the present invention, exhibits a high inhibitory ability on euchromatic histone-lysine N-methyltransferase 2 (EHMT2), and thus, the compound can be usefully used for the treatment of cancer.


Find Patent Forward Citations

Loading…